{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T04:58:35Z","timestamp":1784264315479,"version":"3.55.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.bone.2020.115308","type":"journal-article","created":{"date-parts":[[2020,3,3]],"date-time":"2020-03-03T02:15:02Z","timestamp":1583201702000},"page":"115308","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Distinct immunopathology in the early stages between different antiresorptives-related osteonecrosis of the jaw-like lesions in mice"],"prefix":"10.1016","volume":"135","author":[{"given":"Hiroki","family":"Hayano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9891-9987","authenticated-orcid":false,"given":"Shinichiro","family":"Kuroshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muneteru","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saki","family":"Tamaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maaya","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Ishisaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Sawase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2020.115308_bb0005","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1200\/JCO.2010.31.3304","article-title":"Randomized, double-blind study of denosumab versus zoledronic acid in the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer) or multiple myeloma","volume":"29","author":"Henry","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bone.2020.115308_bb0010","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0140-6736(10)62344-6","article-title":"Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study","volume":"377","author":"Fizazi","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.bone.2020.115308_bb0015","doi-asserted-by":"crossref","first-page":"5132","DOI":"10.1200\/JCO.2010.29.7101","article-title":"Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind study","volume":"28","author":"Stopeck","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bone.2020.115308_bb0020","first-page":"3625","article-title":"Clinical efficacy of denosumab versus bisphosphonates for the prevention of bone complications: implications for nursing","volume":"23","author":"Campbell-Baird","year":"2015","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.bone.2020.115308_bb0025","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.joms.2009.10.010","article-title":"Osteonecrosis of the jaw in a patient on denosumab","volume":"68","author":"Aghaloo","year":"2010","journal-title":"J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.bone.2020.115308_bb0030","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","article-title":"Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic","volume":"61","author":"Marx","year":"2003","journal-title":"J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.bone.2020.115308_bb0035","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1177\/154405910708601102","article-title":"Mechanism of action, pharmacokinetic and pharmacodynamic profile, and clinical applications of nitrogen-containing bisphosphonates","volume":"86","author":"Kimmel","year":"2007","journal-title":"J. Dent. Res."},{"key":"10.1016\/j.bone.2020.115308_bb0040","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.bone.2010.11.020","article-title":"Denosumab and bisphosphonates: different mechanisms of action and effects","volume":"48","author":"Baron","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.bone.2020.115308_bb0045","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/jbmr.3292","article-title":"Transplantation of noncultured stromal vascular fraction cells of adipose tissue ameliorates osteonecrosis of the jaw-like lesions in mice","volume":"33","author":"Kuroshima","year":"2018","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2020.115308_bb0050","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.ijom.2015.01.026","article-title":"Treatment strategies and outcomes of bisphosphonate-related osteonecrosis of the jaw (BRONJ) with characterization of patients: a systematic review","volume":"44","author":"Fliefel","year":"2015","journal-title":"Int. J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.bone.2020.115308_bb0055","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1002\/jbmr.2490","article-title":"OPG-Fc but not zoledronic acid discontinuation reverses osteonecrosis of the jaws (ONJ) in mice","volume":"30","author":"de Molon","year":"2015","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2020.115308_bb0060","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.bone.2016.06.011","article-title":"Osteonecrosis of the jaws (ONJ) in mice after extraction of teeth with periradicular disease","volume":"90","author":"Soundia","year":"2016","journal-title":"Bone"},{"key":"10.1016\/j.bone.2020.115308_bb0065","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/jbmr.2097","article-title":"RANKL inhibitors induce osteonecrosis of the jaw in mice with periapical disease","volume":"29","author":"Aghaloo","year":"2014","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2020.115308_bb0070","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1016\/j.ajpath.2014.07.010","article-title":"Impaired bone resorption and woven bone formation are associated with development of osteonecrosis of the jaw-like lesions by bisphosphonate and anti-receptor activator of NF-\u03baB ligand antibody in mice","volume":"184","author":"Williams","year":"2014","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bone.2020.115308_bb0075","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","article-title":"American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw\u20142014 update","volume":"72","author":"Ruggiero","year":"2014","journal-title":"J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.bone.2020.115308_bb0080","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jbmr.2405","article-title":"Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus","volume":"30","author":"Khan","year":"2015","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2020.115308_bb0085","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.bone.2013.05.013","article-title":"Chemotherapeutic and antiresorptive combination therapy suppressed lymphangiogenesis and induced osteonecrosis of the jaw-like lesions in mice","volume":"56","author":"Kuroshima","year":"2013","journal-title":"Bone"},{"key":"10.1016\/j.bone.2020.115308_bb0090","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.1158\/1078-0432.CCR-13-0042","article-title":"IL-17-mediated M1\/M2 macrophage alteration contributes to pathogenesis of bisphosphonate-related osteonecrosis of the jaws","volume":"19","author":"Zhang","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bone.2020.115308_bb0095","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/path.1942","volume":"209","author":"Schledzewski","year":"2006","journal-title":"J. Pathol."},{"key":"10.1016\/j.bone.2020.115308_bb0100","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1172\/JCI23874","article-title":"Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages","volume":"115","author":"Maruyama","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bone.2020.115308_bb0105","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1111\/j.1582-4934.2009.00810.x","article-title":"Immune cells and angiogenesis","volume":"13","author":"Ribatti","year":"2009","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.bone.2020.115308_bb0110","doi-asserted-by":"crossref","first-page":"4608","DOI":"10.4049\/jimmunol.1202600","article-title":"Normal dendritic cell mobilization to lymph nodes under conditions of severe lymphatic hypoplasia","volume":"190","author":"Platt","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.bone.2020.115308_bb0115","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1158\/1078-0432.CCR-14-1339","article-title":"Curing mice with large tumors by locally delivering combinations of immunomodulatory antibodies","volume":"21","author":"Dai","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bone.2020.115308_bb0120","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s00784-015-1550-0","article-title":"Mouse anti-RANKL antibody delays oral wound healing and increases TRAP-positive mononuclear cells in bone marrow","volume":"20","author":"Kuroshima","year":"2016","journal-title":"Clin. Oral Investig."},{"key":"10.1016\/j.bone.2020.115308_bb0125","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.bone.2018.05.001","article-title":"Prevalence of bisphosphonate-related osteonecrosis of the jaw-like lesions is increased in a chemotherapeutic dose-dependent manner in mice","volume":"112","author":"Kuroshima","year":"2018","journal-title":"Bone"},{"key":"10.1016\/j.bone.2020.115308_bb0130","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1002\/jbmr.141","article-title":"Guidelines for assessment of bone microstructure in rodents using micro-computed tomography","volume":"25","author":"Bouxsein","year":"2010","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2020.115308_bb0135","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.tripleo.2007.08.040","article-title":"Bisphosphonate-associated jawbone osteonecrosis: a correlation between imaging techniques and histopathology","volume":"105","author":"Bedogni","year":"2008","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod."},{"key":"10.1016\/j.bone.2020.115308_bb0140","first-page":"21","article-title":"Definition of bone necrosis by the pathologist","volume":"4","author":"Fondi","year":"2007","journal-title":"Clin. Cases Miner. Bone Metab."},{"key":"10.1016\/j.bone.2020.115308_bb0145","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.oooo.2014.04.017","article-title":"Bisphosphonate-induced osteonecrosis of the jaws: clinical, imaging, and histopathology findings","volume":"118","author":"Franco-Pretto","year":"2014","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"key":"10.1016\/j.bone.2020.115308_bb0150","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.3109\/00016357.2013.765592","article-title":"Histological findings on jaw osteonecrosis associated with bisphosphonates (BONJ) or with radiotherapy (ORN) in humans","volume":"71","author":"Carmagnola","year":"2013","journal-title":"Acta Odontol. Scand."},{"key":"10.1016\/j.bone.2020.115308_bb0155","doi-asserted-by":"crossref","first-page":"e0128021","DOI":"10.1371\/journal.pone.0128021","article-title":"Intramembranous bone healing process subsequent to tooth extraction in mice: micro-computed tomography, histomorphometric and molecular characterization","volume":"10","author":"Vieira","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bone.2020.115308_bb0160","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s00774-017-0872-1","article-title":"Effect of anti-angiogenesis induced by chemotherapeutic monotherapy, chemotherapeutic\/bisphosphonate combination therapy and anti-VEGFA mAb therapy on tooth extraction socket healing in mice","volume":"36","author":"Akita","year":"2018","journal-title":"J. Bone Miner. Metab."},{"key":"10.1016\/j.bone.2020.115308_bb0165","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00774-009-0128-9","article-title":"Zoledronic acid delays wound healing of the tooth extraction socket, inhibits oral epithelial cell migration, and promotes proliferation and adhesion to hydroxyapatite of oral bacteria, without causing osteonecrosis of the jaw, in mice","volume":"28","author":"Kobayashi","year":"2010","journal-title":"J. Bone Miner. Metab."},{"key":"10.1016\/j.bone.2020.115308_bb0170","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1158\/1078-0432.CCR-10-1614","article-title":"Effect of zoledronate on oral wound healing in rats","volume":"17","author":"Yamashita","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bone.2020.115308_bb0175","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.bone.2012.11.030","article-title":"Equilibrium-dependent bisphosphonate interaction with crystalline bone mineral explains anti-resorptive pharmacokinetics and prevalence of osteonecrosis of the jaw in rats","volume":"53","author":"Park","year":"2013","journal-title":"Bone"},{"key":"10.1016\/j.bone.2020.115308_bb0180","doi-asserted-by":"crossref","first-page":"37023","DOI":"10.1074\/jbc.M111.246280","article-title":"Increased bone mass in mice after single injection of anti-receptor activator of nuclear factor-kappaB ligand-neutralizing antibody: evidence for bone anabolic effect of parathyroid hormone in mice with few osteoclasts","volume":"286","author":"Furuya","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2020.115308_bb0185","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","article-title":"Dose translation from animal to human studies revisited","volume":"22","author":"Reagan-Shaw","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.bone.2020.115308_bb0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0019389","article-title":"Zoledronic acid preserves bone structure and increases survival but does not limit tumour incidence in a prostate cancer bone metastasis model","volume":"6","author":"Hung","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.bone.2020.115308_bb0195","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1016\/j.joms.2010.05.003","article-title":"Radiographic findings in bisphosphonate-treated patients with stage 0 disease in the absence of bone exposure","volume":"68","author":"Hutchinson","year":"2010","journal-title":"J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.bone.2020.115308_bb0200","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/380435a0","article-title":"Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele","volume":"380","author":"Carmeliet","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.bone.2020.115308_bb0205","first-page":"1878","article-title":"Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer","volume":"60","author":"Browder","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.bone.2020.115308_bb0210","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.bone.2009.07.011","article-title":"Bisphosphonate-associated osteonecrosis of the jaw: a key role of inflammation?","volume":"45","author":"Lesclous","year":"2009","journal-title":"Bone"},{"key":"10.1016\/j.bone.2020.115308_bb0215","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1600-0714.2006.00391.x","article-title":"Osteonecrosis of the jaws in patients treated with bisphosphonates - histomorphologic analysis in comparison with infected osteoradionecrosis","volume":"35","author":"Hansen","year":"2006","journal-title":"J. Oral Pathol. Med."},{"key":"10.1016\/j.bone.2020.115308_bb0220","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s10549-010-0866-3","article-title":"Bevacizumab and osteonecrosis of the jaw: incidence and association with bisphosphonate therapy in three large prospective trials in advanced breast cancer","volume":"122","author":"Guarneri","year":"2010","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.bone.2020.115308_bb0225","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1136\/jclinpath-2015-203248","article-title":"Denosumab treated giant cell tumour of bone: a morphological, immunohistochemical and molecular analysis of a series","volume":"69","author":"Girolami","year":"2016","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.bone.2020.115308_bb0230","doi-asserted-by":"crossref","first-page":"6799","DOI":"10.1074\/jbc.M109434200","article-title":"TNF-related activation-induced cytokine (TRANCE) induces angiogenesis through the activation of Src and phospholipase C (PLC) in human endothelial cells","volume":"277","author":"Kim","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2020.115308_bb0235","doi-asserted-by":"crossref","first-page":"39548","DOI":"10.1074\/jbc.M300539200","article-title":"Vascular endothelial growth factor up-regulates expression of receptor activator of NF-kappa B (RANK) in endothelial cells. Concomitant increase of angiogenic responses to RANK ligand","volume":"278","author":"Min","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2020.115308_bb0240","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1182\/blood-2006-06-029298","article-title":"Receptor activator of nuclear factor (NF)-kappaB ligand (RANKL) increases vascular permeability: impaired permeability and angiogenesis in eNOS-deficient mice","volume":"109","author":"Min","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bone.2020.115308_bb0245","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1083\/jcb.144.4.789","article-title":"LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan","volume":"144","author":"Banerji","year":"1999","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bone.2020.115308_bb0250","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/aja.1001910407","article-title":"Comparative morphology and morphometry of alveolar macrophages from six species","volume":"191","author":"Haley","year":"1991","journal-title":"Am. J. Anat."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328220300880?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328220300880?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T17:45:53Z","timestamp":1757612753000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328220300880"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":50,"alternative-id":["S8756328220300880"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2020.115308","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Distinct immunopathology in the early stages between different antiresorptives-related osteonecrosis of the jaw-like lesions in mice","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2020.115308","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115308"}}